Search

EuCanImage

EuCanImage

AI-powered precision for cancer imaging

Integrates imaging data with health records to enhance cancer diagnosis and treatment planning, supporting collaborative research and AI development.
#94 in "Healthcare
Price: Paid

Desktop

Visit website
0%
Overview
Use cases
Features and Use Cases
Users & Stats
Pricing
FAQ
Pricing & discounts
UX/UI review
Video review
Reviews
Youtube reviews
Team
Founder interview
Funding
Overview
Use cases
Features and Use Cases
Users & Stats
Pricing
FAQ
Pricing & discounts
UX/UI review
Video review
Reviews
Youtube reviews
Team
Founder interview
Funding

Overview

EuCanImage is a groundbreaking European project in  Healthcare  aimed at enhancing AI in oncology through a secure, federated cancer imaging platform. It offers a scalable and GDPR-compliant infrastructure, linking high-quality imaging datasets to biological and health data. Key features include user-friendly data curation, AI development tools, and a benchmarking platform. EuCanImage promotes precision oncology by improving clinical trust and adoption, facilitating responsible data sharing, and addressing unmet clinical needs in personalized cancer care. With  ai for cancer , this platform is pivotal for researchers and clinicians, making advanced cancer imaging more accessible and efficient.

Use cases

  • Clinical Research: EuCanImage aids researchers by providing access to a vast, federated cancer imaging database, essential for developing new diagnostic and treatment methodologies. Its integration of imaging and health data supports comprehensive studies on cancer's biological aspects.
  • Data Curation and Annotation: The platform offers tools for efficient data curation, anonymization, and enhancement, making it easier for researchers to prepare high-quality datasets for analysis. This feature ensures that data is consistently reliable and usable across different studies.
  • AI Model Development: Researchers can leverage the AI development tools on EuCanImage to create and test machine learning models for cancer detection and treatment prediction. The platform supports federated learning, ensuring data privacy while allowing robust model training.
  • Clinical Decision Support: By linking imaging data with clinical outcomes, EuCanImage helps develop AI-powered decision support systems. These systems can assist clinicians in making more accurate diagnoses and personalized treatment plans, improving patient care.
  • Benchmarking and Validation: The platform includes a benchmarking tool to evaluate AI models against standardized metrics. This ensures that developed models meet clinical efficacy and safety standards before deployment in real-world scenarios.

FAQ

EuCanImage is a European project focused on enhancing cancer imaging through a secure, federated platform. It integrates imaging data with biological and health records to improve cancer diagnosis and treatment.

Researchers, clinicians, and data scientists involved in oncology can use EuCanImage for data integration, AI development, and collaborative research.

EuCanImage complies with GDPR and uses advanced data anonymization and secure data sharing practices to protect patient privacy.

EuCanImage primarily focuses on breast, liver, and colorectal cancers, providing specialized tools and datasets for these types.

Yes, institutions and researchers can contribute their cancer imaging data, which will be curated and anonymized for use in the platform.

EuCanImage offers a machine learning toolbox, a cancer radiomics library, and a cloud-based collaborative environment for developing AI solutions.

Pricing & discounts

EuCanImage offers custom pricing tailored to the specific needs of its users. To get detailed information and a quote, you need to contact their team directly. This ensures you receive a pricing plan that fits your organization's requirements and usage.

User Reviews

There are no reviews here yet. Be the first to leave review.

Hi, there!

Join our newsletter

Stay in the know on the latest alpha, news and product updates.